AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Smiths Group PLC

Director's Dealing Sep 29, 2021

4613_dirs_2021-09-29_75893e0a-b38d-4b17-beda-6421ea073195.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 4096N

Smiths Group PLC

29 September 2021

SMITHS GROUP PLC

Legal Entity Identifier (LEI): 213800MJL6IPZS3ASA11

Notification of Proposed Transactions by Person Discharging Managerial Responsibilities

Smiths Group plc ("the Company") announces that on 28 September 2021, Karin Hoeing, a Non-executive Director, entered into a binding commitment via a trading plan, to purchase Ordinary Shares of the Company on a quarterly basis using £1,100 deducted each month from the after-tax fees she receives from the Company.  The first purchase will occur on 1 November 2021 with subsequent purchases to occur on or around the first business day of each quarter of the Company's financial year. 

Enquiries:

Jemma Spalton, Director of Investor Relations

Smiths Group plc

+44 (0) 20 7004 1600

[email protected]

Matthew Whyte, Company Secretary

Smiths Group plc

+44 (0) 20 7004 1600

[email protected]

About Smiths Group

Smiths is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY).  Its businesses share the same characteristics (technology differentiation; increasing digitisation; sustainably competitive; and a high proportion of recurring revenues generated by aftermarket and services) and a common operating model (The Smiths Excellence System).  For more information visit www.smiths.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHDKCBNDBKDBCB

Talk to a Data Expert

Have a question? We'll get back to you promptly.